Arjil Pharmaceuticals LLC   Report issue

For profit Phase 2
Founded: Hsinchu City Taiwan (2014)

Organization Overview

First Clinical Trial
2020
NCT04220411
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Arjil Pharmaceuticals LLC